Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mechanistic Basis for In Vivo Therapeutic Efficacy of CK2 Inhibitor CX-4945 in Acute Myeloid Leukemia
Morgann Klink, Mohammad Atiqur Rahman, Chunhua Song, et al.
Cancers (2021) Vol. 13, Iss. 5, pp. 1127-1127
Open Access | Times Cited: 13

Showing 13 citing articles:

Casein Kinase 2 (CK2): A Possible Therapeutic Target in Acute Myeloid Leukemia
Øystein Bruserud, Håkon Reikvam
Cancers (2023) Vol. 15, Iss. 14, pp. 3711-3711
Open Access | Times Cited: 11
CX-4945 inhibits fibroblast-like synoviocytes functions through the CK2-p53 axis to reduce rheumatoid arthritis disease severity
Yanping Luo, Yunxuan Lei, Xin Guo, et al.
International Immunopharmacology (2023) Vol. 119, pp. 110163-110163
Closed Access | Times Cited: 7
Targeting of Protein Kinase CK2 in Acute Myeloid Leukemia Cells Using the Clinical-Grade Synthetic-Peptide CIGB-300
Mauro Rosales, George Perez, Ailyn C. Ramòn, et al.
Biomedicines (2021) Vol. 9, Iss. 7, pp. 766-766
Open Access | Times Cited: 17
Signaling Pathways and Therapeutic Strategies in Advanced Basal Cell Carcinoma
Giulia Vallini, Laura Calabrese, Costanza Canino, et al.
Cells (2023) Vol. 12, Iss. 21, pp. 2534-2534
Open Access | Times Cited: 5
Gene expression profiling unveils the temporal dynamics of CIGB-300-regulated transcriptome in AML cell lines
Dania Vázquez‐Blomquist, Ailyn C. Ramòn, Mauro Rosales, et al.
BMC Genomics (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 4
Targeting of Protein Kinase CK2 in Acute Myeloid Leukemia Cells Using the Clinical-Grade Synthetic-Peptide CIGB-300
Mauro Rosales, George Perez, Ailyn C. Ramòn, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 9
Protein Kinase CK2 and Epstein–Barr Virus
Mathias Montenarh, Friedrich A. Grässer, Claudia Götz
Biomedicines (2023) Vol. 11, Iss. 2, pp. 358-358
Open Access | Times Cited: 3
CIGB-300-Regulated Proteome Reveals Common and Tailored Response Patterns of AML Cells to CK2 Inhibition
Mauro Rosales, Arielis Rodríguez‐Ulloa, George Perez, et al.
Frontiers in Molecular Biosciences (2022) Vol. 9
Open Access | Times Cited: 5
Anti-adipogenic and Pro-lipolytic Effects on 3T3-L1 Preadipocytes by CX-4945, an Inhibitor of Casein Kinase 2
Anil Yadav, Byeong‐Churl Jang
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 13, pp. 7274-7274
Open Access | Times Cited: 4
Discovery of a novel, selective CK2 inhibitor class with an unusual basic scaffold
Hend Khalifa, Ahmed K. ElHady, Ting Liu, et al.
European Journal of Medicinal Chemistry (2024) Vol. 282, pp. 117048-117048
Open Access
Validation of an LC–MS/MS Method for the Quantification of the CK2 Inhibitor Silmitasertib (CX-4945) in Human Plasma
Rico Schwarz, Anna Richter, Elisabeth R. D. Seiler, et al.
Molecules (2022) Vol. 27, Iss. 8, pp. 2394-2394
Open Access | Times Cited: 2
Recent Advances in Protein Kinase CK2, a Potential Therapeutic Target in Cancer
V. B. Nipun, K. A. Amin
Russian Journal of Bioorganic Chemistry (2022) Vol. 48, Iss. 5, pp. 919-931
Closed Access | Times Cited: 2
Gene Expression Profiling Unveils the Temporal Dynamics of CIGB-300-Regulated Transcriptome in AML Cells
Dania Vázquez‐Blomquist, Ailyn C. Ramòn, Mauro Rosales, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Page 1

Scroll to top